drug resistance

You have access
Development of Stemness in Cancer Cell Lines Resistant to the Anticancer Effects of Zoledronic Acid
AKIRA YOSHIYAMA, TAKESHI MORII, KOUKI OHTSUKA, HIROAKI OHNISHI, TAKASHI TAJIMA, TAKAYUKI AOYAGI, KAZUO MOCHIZUKI, KAZUHIKO SATOMI and SHOICHI ICHIMURA

Anticancer Research February 2016, 36 (2) 625-631;
You have access
Role of DNA Methylation in Cabazitaxel Resistance in Prostate Cancer
KAVITHA RAMACHANDRAN, CARL SPEER, LUBOV NATHANSON, MARTHA CLAROS and RAKESH SINGAL

Anticancer Research January 2016, 36 (1) 161-168;
You have access
TAS-102 an Emerging Oral Fluoropyrimidine
JIEZHONG CHEN, MEI HAN and MUHAMMAD WASIF SAIF

Anticancer Research January 2016, 36 (1) 21-26;
You have access
Targeted Therapy for Resistant Cholangiocarcinoma with Bevacizumab or Cetuximab Added to Failed Cytotoxic Drug Cores
HOWARD W. BRUCKNER, AZRIEL HIRSCHFELD and MYRON SCHWARTZ

Anticancer Research January 2016, 36 (1) 399-402;
You have access
Molecular Docking Analysis of Steroid-based Copper Transporter 1 Inhibitors
ONAT KADIOGLU, JULIANNA SERLY, EAN-JEONG SEO, IRÉN VINCZE, CSABA SOMLAI, MOHAMED E.M. SAEED, JÓZSEF MOLNÁR and THOMAS EFFERTH

Anticancer Research December 2015, 35 (12) 6505-6508;
You have access
Combination of Genistein and Cisplatin with Two Designed Monofunctional Platinum Agents in Human Ovarian Tumour Models
LAILA ARZUMAN, PHILIP BEALE, NICK PROSCHOGO, JUN Q. YU and FAZLUL HUQ

Anticancer Research November 2015, 35 (11) 6027-6039;
You have access
Reversal of c-MET-mediated Resistance to Cytotoxic Anticancer Drugs by a Novel c-MET Inhibitor TAS-115
EIJI KUNII, HIROAKI OZASA, TETSUYA OGURI, KEN MAENO, SATOSHI FUKUDA, TAKEHIRO UEMURA, OSAMU TAKAKUWA, HIROTSUGU OHKUBO, MASAYA TAKEMURA and AKIO NIIMI

Anticancer Research October 2015, 35 (10) 5241-5247;
You have access
Monofunctional Platinum-containing Pyridine-based Ligand Acts Synergistically in Combination with the Phytochemicals Curcumin and Quercetin in Human Ovarian Tumour Models
LAILA ARZUMAN, PHILIP BEALE, JUN Q. YU and FAZLUL HUQ

Anticancer Research May 2015, 35 (5) 2783-2794;
You have access
A Novel Cytidine Analog, RX-3117, Shows Potent Efficacy in Xenograft Models, even in Tumors that Are Resistant to Gemcitabine
MI YOUNG YANG, YOUNG BOK LEE, CHANG-HO AHN, JOEL KAYE, TANIA FINE, RINA KASHI, OSNAT OHNE, KEES SMID, GODEFRIDUS J. PETERS and DEOG JOONG KIM

Anticancer Research December 2014, 34 (12) 6951-6959;
You have access
Doxorubicin Overcomes Resistance to Drozitumab by Antagonizing Inhibitor of Apoptosis Proteins (IAPs)
IRENE ZINONOS, AGATHA LABRINIDIS, VASILIOS LIAPIS, SHELLEY HAY, VASILIOS PANAGOPOULOS, MARK DENICHILO, VLADIMIR PONOMAREV, WENDY INGMAN, GERALD J. ATKINS, DAVID M. FINDLAY, ANDREW C.W. ZANNETTINO and ANDREAS EVDOKIOU

Anticancer Research December 2014, 34 (12) 7007-7020;

Main menu

User menu

Search

drug resistance

Pages